Investments
88Portfolio Exits
49About Adage Capital Management
Adage Capital Management is a Boston-based $8.9B Money Management firm focused on managing S&P 500 assets predominantly for Endowments and Foundations such as Harvard University, Northwestern University, Dartmouth College, the American Red Cross and the Getty Foundation. Adage and its predecessor, the Select Equity Group at the Harvard Management Company, has outperformed the S&P index in each of the last 15 years by an average of 3.5%. The fund is run by Phill Gross, who prior to founding Adage, was a Healthcare and Retail analyst, equity research director and partner at the Harvard Management Company for 18 years.

Want to inform investors similar to Adage Capital Management about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Latest Adage Capital Management News
Mar 11, 2022
Menlo Micro raised $150 million in Series C led by Vertical Venture Partners and Tony Fadell’s Future Shape where new investors Fidelity Management & Research Company, DBL Partners and Adage Capital Management along with existing investors, Standard Investments, Paladin Capital Group, Piva Capital, and PeopleFund also participated. Menlo Micro is a technology company based in Irvine, California that uses advances in material science to create Microelectromechanical system switches. The funds will allow the company to expand its manufacturing in the United States and to accelerate the development of its power roadmap to address challenges. Menlo Micro stated that the funding will be used to expand the company's domestic manufacturing and supply chain for the Ideal Switch, a device that combines the benefits of a mechanical relay and a semiconductor switch and is 'tiny, fast, reliable, withstands extreme temperatures, is ultra-low loss, and can handle 1,000 Watts.' It is also made with standard semiconductor equipment.
Adage Capital Management Investments
88 Investments
Adage Capital Management has made 88 investments. Their latest investment was in Gracell Biotechnologies as part of their PIPE on August 8, 2023.

Adage Capital Management Investments Activity

Date | Round | Company | Amount | New? | Co-Investors | Sources |
---|---|---|---|---|---|---|
8/7/2023 | PIPE | Gracell Biotechnologies | $100M | Yes | 1 | |
7/13/2023 | Series D - III | HawkEye 360 | $58M | No | 6 | |
7/3/2023 | PIPE | Abeona Therapeutics | $25M | Yes | Adage Capital Management, Nantahala Capital Management, and Undisclosed Investors | 2 |
5/16/2023 | PIPE - III | |||||
10/10/2022 | PIPE |
Date | 8/7/2023 | 7/13/2023 | 7/3/2023 | 5/16/2023 | 10/10/2022 |
---|---|---|---|---|---|
Round | PIPE | Series D - III | PIPE | PIPE - III | PIPE |
Company | Gracell Biotechnologies | HawkEye 360 | Abeona Therapeutics | ||
Amount | $100M | $58M | $25M | ||
New? | Yes | No | Yes | ||
Co-Investors | Adage Capital Management, Nantahala Capital Management, and Undisclosed Investors | ||||
Sources | 1 | 6 | 2 |
Adage Capital Management Portfolio Exits
49 Portfolio Exits
Adage Capital Management has 49 portfolio exits. Their latest portfolio exit was CervoMed on August 16, 2023.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
---|---|---|---|---|---|
8/16/2023 | Reverse Merger | 3 | |||
7/11/2022 | Acquired | 9 | |||
5/6/2022 | IPO | Public | 1 | ||
Date | 8/16/2023 | 7/11/2022 | 5/6/2022 | ||
---|---|---|---|---|---|
Exit | Reverse Merger | Acquired | IPO | ||
Companies | |||||
Valuation | |||||
Acquirer | Public | ||||
Sources | 3 | 9 | 1 |
Adage Capital Management Team
1 Team Member
Adage Capital Management has 1 team member, including current Managing Director, Phill Gross.
Name | Work History | Title | Status |
---|---|---|---|
Phill Gross | Managing Director | Current |
Name | Phill Gross |
---|---|
Work History | |
Title | Managing Director |
Status | Current |